World Health Summit
2021-10-24 - 2021-10-26 | Berlin, Germany
The World Health Summit promotes a science-driven and broad approach to global health development with the Sustainable Development Goals (SDGs) at its core. Our key issues are therefore interdisciplinary, science-based, cross-sectoral, and concerted. They are vital to set the global health agenda for the years to come. Because health is more than medicine and health is a human right. Key issues include:

Access to Essential Medicine
Big Data
Biomedical Research
Climate Change and Health
Digital Innovation
Drugs and Vaccines
Evolutionary Medicine
Global Action Plan for Healthy Lives and Well-being for All
Global Health Security
Health in All Policies
Health Systems Strengthening
Pandemic Preparedness
Patient Safety
Planetary Health
Sustainable Development Goals (SDGs)
Translational Science
Universal Health Coverage

Click here to learn more.

BARDA Industry Day
2021-11-03 - 2021-11-04
BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the Health Security space.
Additional details forthcoming.

World Antimicrobial Resistance Congress 2021
2021-11-08 - 2021-11-09 | Washington DC
Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050. Yet combatting resistance globally and developing a robust arsenal of antibiotics continues to fall behind the pace of resistance.
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue.
Industry leaders, innovative technology and solution providers, public authorities, international organizations, infectious disease clinicians, pharmacists and microbiologists are some of the 1,000+ attendees from over 50 countries who will gather this November 2021 at the World Anti-Microbial Resistance Congress.
The conference will gather global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on the following areas:

Advancing antibiotic R&D and non-traditional therapies development
Enhancing the commercial landscape and marketplace for antibiotics and diagnostics
Developing innovative diagnostics solutions
Facilitating interactions between funders and developers
Improving antimicrobial stewardship guidelines and practice through technology
Implementing sustainable environmental and manufacturing practices
Tackling infection control at hospitals efficiently and cost-effectively
Applying genomics to easily detect resistant pathogens and to accelerate antibiotic R&D
Leveraging surveillance platforms and solutions to monitor outbreaks and increasing numbers of resistant pathogens locally, regionally, nationally and globally.

If you work in these key areas of AMR, then you must attend the World Anti-Microbial Resistance Congress 2021!
Click here to learn more.
Click here to view the agenda.
Click here to register.

9th ASM Conference on Biofilms
2021-11-14 - 2021-11-18 | Charlotte, North Carolina
The 9th ASM Conference on Biofilms will be coming to Charlotte, N.C. on Nov. 14 –18, 2021. Additional Details Forthcoming.
Biofilms have a tremendous impact on industrial, clinical and natural environments. 2021 ASM Biofilms will provide an interdisciplinary platform to discuss the latest biofilm research. Check back later for more details about the meeting. We look forward to seeing you next year.
Click here to learn more.
Click here to view the agenda.

3rd SCI-RSC Symposium on Antimicrobial Drug Discovery
2021-11-15 - 2021-11-16 | SCI, 14/15 Belgrave Square, London, SW1X 8PS, United Kingdom
At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.
Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.
Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery. And with great opportunities for academic–industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.
Click here to learn more.
Email conferences@soci.org to register your interest.
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org

EFPIA - Pandemic Prevention: how Europe can lead the fight against AMR
2021-11-16 08:00 - 09:30 (America/New_York) | VIRTUAL EVENT
You’re invited to join this virtual event on Tuesday, 16 November, 2021 at 14:00 – 15:30 CET.
The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.
The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to perform. In the Pharmaceutical Strategy for Europe, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed, spotlighting 2022 as the year when change needs to happen.

Join us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.

CARB-X participants include Kevin Outterson, Executive Director.
Click here to learn more and register.

McGill AMR Innovation Summit
2021-11-19 14:00 - 15:00 (America/New_York) | VIRTUAL EVENT
Antimicrobials in the era of AMR
During World Antimicrobial Awareness Week (Nov. 18-24 2021), the McGill AMR Centre and Innovation + Partnership office are hosting the inaugural McGill AMR Innovation Summit, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between McGill scientists and non-academic stakeholders.
Program

14:00-14:30 Keynote speaker Erin Duffy, PhD (public event)
14:30-15:00 Panel discussion (public event)
15:00-16:00 Industry-Academic networking event (private event)

Keynote speaker Erin Duffy, PhD, Chief of R&D, CARB-X
CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$480 million to invest in 2016-22, CARB-X portfolio is the world’s largest early development pipeline in AMR.
Panel discussion Challenges and opportunities for antimicrobial R&D in the era of AMR
With experts from industry and academia.
• David Claveau, PhD, Director, Medical Affairs at AVIR Pharma
• Erin Duffy, PhD, Chief of Research & Development, CARB-X
• Joseph Mancini, PhD, Head of Pharmacology and Biologics, Senior Director at adMare BioInnovations
• Nicolas Moitessier, PhD, Professor in Chemistry (McGill), co-founder of Molecular Forecaster
• Martin Schmeing, PhD, Professor in Biochemistry (McGill), Director of Centre for Structural Biology
• Christopher Tan, PhD, Director, Business Development & Licensing, Search & Evaluation, Infectious Diseases & Vaccines at Merck Research Laboratories
Registration is free but required.
If you have any questions, please contact us at amrcentre@mcgill.ca
Click here to learn more.
Click here to register.

AMR Industry Alliance Panel on Supporting the Optimal Use of Antimicrobial Medicines through Innovation
2021-11-23 07:00 - 08:00 (America/New_York) | VIRTUAL EVENT
This year’s WAAW will take place 18-24 November 2021, with the theme “Spread Awareness, Stop Resistance”. You can read more about WHO’s WAAW campaign here.
The AMR Industry Alliance virtual panel session will be organized as short dialogues among experts from the public, private, academic and civil society sectors who will discuss key topics related to the optimal use of antimicrobial medicines as a means of controlling the spread of antimicrobial resistance (AMR).
The three short dialogues will focus on the following topics:

The role of diagnostics in guiding optimal use of antibiotics
Relevance of AMR stewardship in achieving the UN SDGs
Stop resistance! Collaborative approaches to tackling AMR

Speakers include:

Hanan H. Balkhy, Assistant-Director-General, AMR, WHO
Thomas Cueni, Chair, AMR Industry Alliance & Director-General, IFPMA
Otridah Kapona, National AMR Focal Point and Coordinator, Zambia National Public Health Institute, WHO STAG-AMR
Cecilia Ferreyra, Head of AMR Programme, FIND
Mukesh Kapila, Global Health and Humanitarian Affairs, University of Manchester, WHO STAG-AMR
Liz Tayler, Team Leader, Monitoring and National Action Plans AMR, WHO
Scott Weese, Professor, Ontario Veterinary College and Director, Centre for Public Health and Zoonoses, University of Guelph
Kevin Outterson, Executive Director, CARB-X
Pilar Ramon Pardo, AMR Advisor, PAHO
Peter Beyer, Senior Advisor and Team Lead, AMR, WHO
Jean-Louis Tissier, Vice-President, Public and Government Affairs, BioMérieux
Adam Zerda, Director, AMR Strategy and Program Development
Greg Frank, Director, Global Public Policy, Merck

Click here to learn more.
Click here to register.

ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
2021-12-08 - 2021-12-09 | VIRTUAL EVENT
The 2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place online, Dec. 8-9, 2021.

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.

Click here to learn more.
Click here to view the agenda.
Click here to register.

Infection 2021: British Society for Antimicrobial Chemotherapy (BSAC) Winter Conference
2021-12-09 - 2021-12-10 | VIRTUAL EVENT
Join us as we celebrate 50 years of BSAC! Infection 2021 is an exciting two-day hybrid conference looking at the challenges and future of infection management and how we can rise the meet the challenge of antimicrobial resistance.
We encourage you to register for either in-person or virtual attendance and submit your abstracts for consideration for oral and poster presentation. All accepted abstracts will be published in JAC-Antimicrobial Resistance.
CARB-X participants include Kevin Outterson, Executive Director, who will be leading the session “The potential of de-linkage in addressing antimicrobial resistance” on Friday December 10th.
Click here to learn more.
Click here to view the agenda.

ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance - Bangkok, Thailand
2021-12-16 - 2021-12-17 | Bangkok, Thailand
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance
Click here to learn more.
Click here to view the agenda.
Click here to register.

Stewardship can accelerate efforts to combat AMR
2022-02-03 18:00 - 19:00 (Asia/Kolkata) | VIRTUAL EVENT
CARB-X Compliance Manager, Rose Garson, will join Taslimarif Saiyed, PhD of Centre for Cellular and Molecular Platforms (C-CAMP) to speak on the role that stewardship and access play in combating #AMR.
✏️ Register: https://bit.ly/3o3op9B

Global Research on Antimicrobial Resistance (GRAM) Virtual Event
2022-02-04 17:00 - 18:30 (Europe/London) | VIRTUAL EVENT
The GRAM report was published in The Lancet on 20 January 2022. The online launch event will explore these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations; celebrate the global collaboration and 100’s of data partnerships that made this study possible; consider how data can be harnessed to support governments, health systems and civil society to act and reduce the human-cost of AMR; and identify immediate actions that can help countries around the world protect their health systems against the threat of AMR.
Confirmed speakers include:

Professor Chris Murray, Director of the Institute for Health Metrics and Evaluation
Dame Sally Davies, UK Special Envoy on AMR
Dr Hanan Balkhy, Assistant Director General for Antimicrobial Resistance, World Health Organization
Dr Richard Horton, Editor-in-Chief of The Lancet

If you can join live register here. Places are limited so please register early to avoid disappointment.
If you cannot join live, but would like to receive the recording, please request the post-event recording here and a link to the recording will be sent once available. Please note a recording will also be shared with those joining live.
The GRAM project is a collaboration led by Institute for Health Metrics and Evaluation and the University of Oxford and was funded by the Fleming Fund, the Bill & Melinda Gates Foundation and Wellcome Trust.
If you have any queries, please email GlobalEvents@wellcome.org

Gordon Research Seminar: Biology of Acute Respiratory Infection (GRS)
2022-02-26 - 2022-02-27 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, United States
Host-pathogen interactions during pulmonary health and disease
The Gordon Research Seminar on Biology of Acute Respiratory Infection is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting-edge ideas.
Chairs: Anukul T. Shenoy and Kristin M. Noell

Gordon Research Conference: Biology of Acute Respiratory Infection
2022-02-27 - 2022-03-04 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, United States
Basic Mechanisms and Translational Science Contributing to the Global Impact of Pneumonia
The 2022 Gordon Research Conference on the Biology of Acute Respiratory Infections will center on biological events dictating pneumonia outcome and the degree to which these events have been or could be leveraged by clinical practice. This will benefit from integrated contributions across multiple disciplines, including but not limited to immunologists, microbiologists, and clinicians, resulting in a venue that uniquely assembles the world’s foremost experts in pneumonia research. In this way, the 2022 GRC on the Biology of Acute Respiratory Infection and the associated Gordon Research Seminar will cultivate an opportunity for creative and multidisciplinary discussions for this rapidly evolving area of investigation, maximizing the potential for innovative discoveries and clinical interventions.
Chairs: Lee J. Quinton and Stephania Cormier
Vice Chairs: Bethany B. Moore and Charles Dela Cruz

The Longitude Prize: AMR& Diagnostic Frontiers: Developing and increasing access to innovative diagnostics in and for low-and-middle-income countries (LMICs)
2022-03-03 14:00 - 16:00 (Europe/London) | VIRTUAL EVENT
Are you developing AMR diagnostics in or for an LMIC? Or do you have a product that could be adapted and tested for use in low resource settings?
Pitch your technology and get customer-driven feedback from a panel of global health representatives at the virtual event with FIND, the global alliance for diagnostics and CARB-X.
Register to pitch your product. Visit the Longitude Prize website for more information and to sign-up to the event.

Gordon Research Seminar: New Antibacterial Discovery and Development
2022-03-05 - 2022-03-06 | Renaissance Tuscany Il Ciocco, Via Giovanni Pascoli, Lucca (Barga), 55051, Italy
The chair is currently developing a description for this conference. This information will be available by May 5, 2021. Please check back for updates.
Click here to learn more.
Click here to register.

Gordon Research Seminar: New Antibacterial Discovery and Development (GRS)
2022-03-05 - 2022-03-06 | Renaissance Tuscany Il Ciocco, Via Giovanni Pascoli, Lucca (Barga), 55051, Italy
The chair is currently developing a description for this conference. This information will be available by May 5, 2021. Please check back for updates.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Gordon Research Conference: New Antibacterial Discovery and Development
2022-03-06 - 2022-03-11 | Renaissance Tuscany Il Ciocco, Via Giovanni Pascoli, Lucca (Barga), 55051, Italy
Applications for this meeting must be submitted by February 6, 2022. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the conference chair if more seats become available due to cancellations.
Click here to learn more.
Click here to register.

BactiVac 3rd Annual Network Meeting
2022-04-01 | Webinar
Further to the postponement of our 3rd Annual Network Meeting in Kenya 24-27 March 2020, we have constantly been reviewing the global situation surrounding COVID-19. As a Network focusing on global health our priority must continue along the lines of taking the required precautions to minimize the spread of the virus. Our commitment to deliver this meeting continues and it is the intention to host this event in Kenya in Spring 2022.
Further details on the exact timing of the event and Programme will be provided in due course.
Click here to learn more.

AMR Conference
2022-04-07 - 2022-04-08 | Congress Center Basel, Messepl. 21, Basel, 4058, Switzerland
The AMR Conference is a platform for subject matter experts (SMEs), start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges in bringing new antimicrobial treatments and diagnostics to the market.

18th International Conference on Pseudomonas
2022-04-18 - 2022-04-23 | Georgia Tech Hotel and Conference Center, 800 Spring St. NW, Atlanta, GA, 30308, United States
The conference promotes academic and social collaborations among all scientists in the research fields of Pseudomonas – the genus that contains human, animal and plant pathogens as well as biocontrol agents.

ECCMID 2022
2022-04-23 - 2022-04-26 | ALTICE ARENA, Rossio dos Olivais, Lote 2.13.01 A, Lisbon, 1990-231, Portugal
Click here to learn more, additional details forthcoming.

Wellcome Connecting Science: Antimicrobial Resistance – Genomes, Big Data and Emerging Technologies (Virtual Conference)
2022-04-27 - 2022-04-29
This year’s program will include antimicrobial discovery and global trends in AMR, in addition to the focus on genomic evidence and the other tools for surveillance. It will highlight the recent advances in the rapidly emerging field of machine learning and GWAS methods to predict AMR. We will also discuss the role of vaccines in AMR, diagnostics, and how to translate the research findings into clinical practice and policy.
This conference will bring together basic researchers, clinicians, computer scientists, and policymakers interested in pathogen genomics, epidemiology and surveillance, machine learning, as well as the development of novel diagnostic and therapeutic tools and approaches.

ASM Microbe 2022
2022-06-09 - 2022-06-13
ASM Microbe connects you to a global network of scientists, researchers and health care professionals. Whether it’s presenting your research to peers and luminaries in your field, or accessing the latest science and novel techniques in your area or related discipline, ASM Microbe is the premier forum to share knowledge and collaborate across the full spectrum of microbiology. Take advantage of the meeting’s interactive learning formats to build a customized experience across 8 scientific tracks.
ASM Microbe 2022 | June 9–13, 2022 • Washington, D.C.
ASM Microbe 2023 | June 15–19, 2023 • Houston, Texas
ASM Microbe 2024 | June 13–17, 2024 • Atlanta, Ga.
ASM Microbe 2025 | June 19–23, 2025 • Los Angeles, Calif.
Click here to learn more.

Public Webinar: How CARB-X Partners are Addressing the Global Health Threat of AMR
2022-06-09 09:00 - 09:30 (America/New_York) | VIRTUAL EVENT
A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them.
The webinar celebrates a recent funding announcement in which BARDA and Wellcome have committed up to an additional US$370 million to CARB-X.
Register in advance to attend:
https://bostonu.zoom.us/meeting/register/tJcvde6grjIjGNNROqfFhs5d6RSiOirgYin9

Global Vaccine and Immunization Research Forum
2022-06-23 09:00 - 12:00 (America/New_York) | VIRTUAL EVENT
Topic:
Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, Challenges and Future Development
Purpose:
Antimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections, reducing antibiotic use and reducing pathogen transmission and chances of developing resistance genes. Increasing evidence from observational and modelling studies show the impact of vaccines on AMR.
However, this evidence is yet to translate to policy and decision making about which vaccines to develop and introduce, so they effectively prevent AMR. This webinar will explore the mechanisms, evidence and value of vaccines in preventing AMR. A panel of experts will discuss the challenges to ensure that vaccines to prevent AMR are developed and widely used.
Registration:
https://who.zoom.us/webinar/register/WN_Iudu_2LtRIqv6hA6IkCkBQ
Audience
Scientists, product developers, regulators, policy makers, implementers and funders interested in the role of vaccines in preventing AMR.
Topics

The threat of AMR and ways through which vaccines can prevent it;
Assessment of the value of vaccines in preventing AMR;
Research priorities on vaccines and AMR;
Development pipeline for vaccines against AMR priority pathogens;
The role of vaccines in National Action Plans on AMR;
Stories from the field: how vaccines were used in Zimbabwe to prevent AMR;
Challenges and opportunities to ensure that vaccines against AMR are developed and used.

About GVIRF
The Global Vaccine and Immunization Research Forum, the central forum for research related to Immunization Agenda 2030, brings together the entire vaccine and immunization research community every two years and is organized by the U.S. National Institute of Allergy and Infectious Diseases, the Bill & Melinda Gates Foundation, and the World Health Organization. Between biennial meetings, a series of webinars is also organized to address emerging issues of interest.

Gordon Research Conference: Bacterial Cell Surfaces
2022-06-26 - 2022-07-01 | Mount Snow, 89 Grand Summit Way, West Dover, VT, United States
The chair is currently developing a description for this conference. Please check back for updates.
Click here to learn more.

Gordon Research Conference: Drug Resistance
2022-06-26 - 2022-07-01 | Bryant University, 1150 Douglas Pike, Smithfield, RI, United States

A Grand Bargain for Antimicrobial Procurement: Leveraging Purchasing Systems to Address AMR
2022-06-30 09:00 - 10:00 (America/New_York) | VIRTUAL EVENT
Join the Center for Global Development for a conversation on new purchasing systems for antimicrobials and the grand bargain stakeholders must strike to govern the global market. This discussion will draw from a new landscape review of antibiotic procurement systems, which synthesized existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system. This research was undertaken as part of CGD’s working group, A Grand Bargain for Antimicrobial Procurement. Speakers will discuss strategies for improving access, stewardship, and innovation for antimicrobials; promising new procurement models; and the rights and responsibilities of stakeholders in both LMICs and HICs to facilitate a healthy pipeline of antimicrobials that defends against AMR.
Presenter
Anthony McDonnell, Senior Policy Analyst, Center for Global Development
Panelists
Kevin Outterson, Executive Director, CARB-X; Professor, Boston University School of Law
Fatema Rafiqi, Research Programme Manager for the Antimicrobial Resistance Benchmark, Access to Medicine Foundation
Rachel Silverman Bonnifield, Policy Fellow, Center for Global Development
Mirfin Mpundu, Director, ReAct Africa
Moderator
Javier Guzman, Director of Global Health Policy and Senior Policy Fellow, Center for Global Development
